EC Number   |
Substrates   |
Products   |
Reversibility   |
|---|
 3.4.24.B11 | aggrecan + H2O |
several cleavage sites are determined |
11 aggrecan fragment |
product determination, overview |
? |
 3.4.24.B11 | aggrecan + H2O |
cleavage site is Glu373-Ala374 |
2 aggrecan fragment |
- |
? |
 3.4.24.B11 | versican isoform V0 + H2O |
a second cleavage site might be Glu405-Gln406, cleavage site is Glu1428-Ala1429 in the V0 isoform, activity with recombinant and native human substrate protein |
2 peptides |
product identification |
? |
 3.4.24.B11 | versican isoform V1 + H2O |
a second cleavage site might be Glu405-Gln406, cleavage site is Glu441-Ala442 in the V1 isoform, activity with recombinant and native human substrate protein |
2 peptides |
product identification |
? |
 3.4.24.B11 | thrombospondin-1 + H2O |
- |
36000 Da fragment + 110000 Da fragment |
- |
? |
 3.4.24.B11 | thrombospondin-2 + H2O |
- |
42000 Da fragment + 30000 Da fragment |
- |
? |
 3.4.24.B11 | aggrecan + H2O |
- |
? |
- |
? |
 3.4.24.B11 | aggrecan + H2O |
C-terminal spacer region of the enzyme is required for activity, substrate is a cartilage proteoglycan, cleavage site is the peptide bond Glu1871-Leu1872 within the substrates chondroitin sulfate attachment domain |
? |
- |
? |
 3.4.24.B11 | aggrecan + H2O |
substrate is a cartilage proteoglycan |
? |
- |
? |
 3.4.24.B11 | aggrecan + H2O |
in 50 mM Tris-HCl, pH 7.6, 150 mM NaCl and 5mM CaCl2 solution with 100 ng recombinant ADAMTS-1 at 37°C |
? |
- |
? |